Completed OBSERVATIONAL NCT06826625

Oxidative Stress in Polycystic Ovary Syndrome

Elucidation of the Oxidative Mechanism Effective in Polycystic Ovary Syndrome: a Randomized Controlled Clinical Study

Sponsor: Mardin Artuklu University

Conditions Oxidative Stress Polycystic Ovarian Syndrome (PCOS)

Updated 2 times since 2025 Last updated: Feb 10, 2025 Started: Jan 2, 2021 Primary completion: Dec 30, 2021 Completion: Feb 1, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06826625, this observational or N/A phase trial focuses on Oxidative Stress and Polycystic Ovarian Syndrome (PCOS) and remains completed. Sponsored by Mardin Artuklu University, it has been updated 2 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

2 versions recorded

Sep 2025 — Present [monthly]

Completed
Mar 2025 — Sep 2025 [monthly]

Completed

First recorded

Jan 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mardin Artuklu University

Data source: Mardin Artuklu University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Antalya, Turkey (Türkiye)